These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7901917)

  • 1. Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy.
    Abelson MB; Schaefer K
    Surv Ophthalmol; 1993; 38 Suppl():115-32. PubMed ID: 7901917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
    Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
    Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New aspects in drug therapy of ocular allergies].
    Maĭchuk IuF
    Vestn Oftalmol; 2000; 116(5):10-4. PubMed ID: 11221368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A current appreciation of sites for pharmacological intervention in allergic conjunctivitis: effects of new topical ocular drugs.
    Yanni JM; Sharif NA; Gamache DA; Miller ST; Weimer LK; Spellman JM
    Acta Ophthalmol Scand Suppl; 1999; (228):33-7. PubMed ID: 10337430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.
    Leonardi A; Quintieri L
    Expert Opin Pharmacother; 2010 Apr; 11(6):969-81. PubMed ID: 20307221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current and future therapy of allergic conjunctivitis.
    Friedlaender MH
    Curr Opin Ophthalmol; 1998 Aug; 9(4):54-8. PubMed ID: 10387470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular allergy treatment comparisons: azelastine and olopatadine.
    Bielory L; Buddiga P; Bigelson S
    Curr Allergy Asthma Rep; 2004 Jul; 4(4):320-5. PubMed ID: 15175148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The central role of conjunctival mast cells in the pathogenesis of ocular allergy.
    Leonardi A
    Curr Allergy Asthma Rep; 2002 Jul; 2(4):325-31. PubMed ID: 12044269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis.
    Mishra GP; Tamboli V; Jwala J; Mitra AK
    Recent Pat Inflamm Allergy Drug Discov; 2011 Jan; 5(1):26-36. PubMed ID: 21171952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in pharmacotherapy for allergic conjunctivitis.
    Abelson MB; Shetty S; Korchak M; Butrus SI; Smith LM
    Expert Opin Pharmacother; 2015 Jun; 16(8):1219-31. PubMed ID: 25943976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular allergy guidelines: a practical treatment algorithm.
    Bielory L
    Drugs; 2002; 62(11):1611-34. PubMed ID: 12109924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular allergy: diagnosis and treatment.
    Butrus S; Portela R
    Ophthalmol Clin North Am; 2005 Dec; 18(4):485-92, v. PubMed ID: 16314214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-inflammatory effects of therapies for ocular allergy.
    Mantelli F; Calder VL; Bonini S
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):786-93. PubMed ID: 24044620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of ocular allergy.
    Schultz BL
    Curr Opin Allergy Clin Immunol; 2006 Oct; 6(5):383-9. PubMed ID: 16954794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of mast cell involvement in allergic conjunctivitis.
    Elieh Ali Komi D; Rambasek T; Bielory L
    Allergy; 2018 Mar; 73(3):528-539. PubMed ID: 29105783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allergic conjunctival disorders].
    Ebihara N
    Nihon Rinsho; 2005 May; 63 Suppl 5():107-13. PubMed ID: 15954334
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of bilastine upon the ocular symptoms of allergic rhinoconjunctivitis.
    Bartra J; Mullol J; Montoro J; Jáuregui I; del Cuvillos A; Dávila I; Ferrer M; Sastre J; Valero A
    J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():24-33. PubMed ID: 22185047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of ocular allergy treatment.
    Friedlaender M
    Curr Allergy Asthma Rep; 2001 Jul; 1(4):375-9. PubMed ID: 11892061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical look at ocular allergy drugs.
    Joseph Titi M
    Am Fam Physician; 1996 Jun; 53(8):2637-42, 2645-6. PubMed ID: 8644576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergic conjunctivitis: a comprehensive review of the literature.
    La Rosa M; Lionetti E; Reibaldi M; Russo A; Longo A; Leonardi S; Tomarchio S; Avitabile T; Reibaldi A
    Ital J Pediatr; 2013 Mar; 39():18. PubMed ID: 23497516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.